Pharma News News & Articles

1 Sarepta Therapeutics Announces Eteplirsen Meets Primary Endpoint of Increased Novel Dystrophin and Achieves Significant Clinical Benefit on 6-Minute Walk Test After 48 Weeks of Treatment in Phase IIb Study in Duchenne Muscular Dystrophy Full Text AVI BioPharma, October 8, 2012

2 Medtronic Launches New Angioplasty Catheter for Below-the-Knee Arteries Full Text Medtronic, October 8, 2012

3 New data from ORIGIN Shows Lantus use is about 3 times more likely to achieve and sustain target HbA1c vs. standard care over 5 years in the study population Full Text Sanofi-aventis, October 8, 2012

4 Medtronic Completes Enrollment in Landmark Study of IN.PACT Drug-Eluting Balloon in Peripheral Artery Disease Full Text Medtronic, October 8, 2012

5 Watson Receives Approval from European Commission for Pending Actavis Acquisition Full Text Watson Pharmaceuticals, October 8, 2012

6 Cell Therapeutics Prices Underwritten Public Offering of $60 Million of Convertible Preferred Stock Full Text Cell Therapeutics, October 8, 2012

7 Bayer Technology Services honors outstanding graduates in biochemical and chemical engineering Full Text BayNews International, October 8, 2012

8 Sarepta Therapeutics Receives Notice From Department of Defense for Termination of Ebola Therapeutic Program Full Text AVI BioPharma, October 8, 2012

9 Bayer HealthCare supports individualized diabetes treatment Full Text BayNews International, October 5, 2012

10 Bayer MaterialScience honored by AkzoNobel A&AC with “The Alliance Award” Reliable partner for innovative and sustainable products Full Text BayNews International, October 5, 2012

11 Medtronic Extends Sponsorship of Twin Cities Marathon, TC 10 Mile and Affiliated Youth Events Full Text Medtronic, October 5, 2012

12 Randomized front line trial utilizing tumor genomic profiling tests OPAXIO plus radiation therapy compared to current standard of care of radiation with temozolamide in high risk patients with glioblastoma multiforme Full Text Cell Therapeutics, October 5, 2012

13 Shionogi-ViiV Healthcare announces completion of initial clinical registration package for dolutegravir in HIV Full Text GlaxoSmithKline, October 5, 2012

14 Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection Full Text Biologics: targets & therapy, October 5, 2012    Clinical Article

15 Cell Therapeutics Announces Proposed Public Offering of Convertible Preferred Stock Full Text Cell Therapeutics, October 5, 2012

16 BioMarin to Host Third Quarter 2012 Financial Results Conference Call and Webcast on Thursday, October Full Text BioMarin, October 5, 2012

17 New Data Reinforce Positive Clinical Outcomes for Direct Aortic Implants Using the Medtronic CoreValve System Full Text Medtronic, October 5, 2012

18 Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension Full Text Medtronic, October 5, 2012

19 Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement Full Text Sanofi-aventis, October 4, 2012

20 FDA approves new subcutaneous ICD Full Text The Clinical Advisor, October 4, 2012

1 Astellas pharma global development announces management reorganization Astellas, April 3, 2013    Free full text

2 Abbott Initiates Voluntary Recall of FreeStyle InsuLinx Blood Glucose Meters in the United States Abbott, April 16, 2013    Free full text

3 Warner Chilcott Announces FDA Approval of New Oral Contraceptive Warner Chilcott, April 25, 2013    Free full text

4 FDA alerts providers to mattress cover safety risks American Hospital Association News, April 29, 2013    Free full text

5 Statement on FOSAMAX (alendronate sodium) Product Liability Trial Merck, March 12, 2013    Free full text

6 FDA alerts providers to drug product recalls American Hospital Association News, March 29, 2013    Free full text

7 Taro Receives FDA Approval For Topicort (desoximetasone) Topical Spray, 0.25% Taro Pharmaceuticals USA, April 15, 2013    Free full text

8 Alcon announces FDA approval of Simbrinza Suspension, a new beta blocker-free, fixed-combination therapy for glaucoma patients Novartis, April 22, 2013    Free full text

9 U.S. FDA Approves INVOKANA (Canagliflozin) to Treat Adults with Type 2 Diabetes Janssen, April 1, 2013    Free full text

10 CryoLife Receives FDA Clearance For Next Generation HeRO Device CryoLife, April 5, 2013    Free full text

11 US District Court rules one PULMICORT RESPULES (budesonide inhalation suspension) patent invalid and another patent not infringed AstraZeneca, April 2, 2013    Free full text

12 FDA approves Diclegis for pregnant women experiencing nausea and vomiting FDA Press Announcements, April 12, 2013    Free full text

13 CEL-SCI Corporation Provides Update on Phase III Clinical Trial CEL-SCI, April 24, 2013    Free full text

14 Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure Astellas, April 16, 2013    Free full text

15 Pfizer Issued Warning Letter for Italian Manufacturing Plant BioPharm International, April 12, 2013    Free full text

16 Valeant Pharmaceuticals Provides Update to Recent Event Valeant Pharmaceuticals International, April 5, 2013    Free full text

17 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries, April 9, 2013    Free full text

18 Astellas pharma us, inc. names new president Astellas, April 3, 2013    Free full text

19 Medivation and astellas provide update on prevail Astellas, April 5, 2013    Free full text

20 Study: Tablets Can Effectively Read EEG Results Healthcare Informatics, April 5, 2013    Free full text